- Home
- NSIT vs MANE Comparison
NSIT vs MANE Comparison
Compare NSIT & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSIT | MANE |
|---|---|---|
| Founded | 1988 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.3B |
| IPO Year | 1996 | 2026 |
Fundamental Metrics
Financial Performance| Metric | NSIT | MANE |
|---|---|---|
| Price | $155.23 | $118.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $116.25 | $83.33 |
| AVG Volume (30 Days) | 282.9K | ★ 590.0K |
| Earning Date | 05-07-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.53 | N/A |
| Revenue | ★ $8,247,180,000.00 | N/A |
| Revenue This Year | $3.79 | N/A |
| Revenue Next Year | $2.16 | N/A |
| P/E Ratio | $43.88 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.62 | $36.26 |
| 52 Week High | $168.50 | $131.24 |
Technical Indicators
Market Signals| Indicator | NSIT | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 59.79 |
| Support Level | $151.82 | $92.62 |
| Resistance Level | $157.35 | $117.89 |
| Average True Range (ATR) | 6.27 | 5.70 |
| MACD | -1.22 | 1.46 |
| Stochastic Oscillator | 18.40 | 70.99 |
Price Performance
Historical ComparisonAbout NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.